~~<i id='F0444687DD'><strike id='F0444687DD'><tt id='F0444687DD'><pre id='F0444687DD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

comprehensive

author：explore 2025-10-01 04:44:58 - browse：8

On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： eGenesis tests gene

hotspot

knowledge

explore

focus

entertainment

leisure time

AlastairGrant/APLONDON—AstraZenecasaidFridayanexperimentaldrugtampeddowntheprogressionofacertaintype

WSS

Hearing on Medicare drug price negotiation gets unusually heated

Intarcia’s device

EpiPen alternative approval delay highlights citizen petition issue

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

STAT Virtual Event: Putting AI to the Test

Readout LOUD podcast: possible new ALS drug, artificial wombs

explore

comprehensive

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Prior authorization will have to move faster under new Biden rule

Psychedelics group wrestles with new pharma identity

The surgeon had a dilemma only a Nazi medical text could resolve

New air purifier tech could be key to improving indoor air quality

Prior authorization will have to move faster under new Biden rule

Wildfire smoke exposes gaps in outdoor worker protections

Second xenotransplant done with gene

Hepatitis C has a cure — but many Americans still lack access to it

Prior authorization will have to move faster under new Biden rule

knowledge

Hearing on Medicare drug price negotiation gets unusually heated

Prior authorization will have to move faster under new Biden rule

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Dewpoint Therapeutics lays off staff after losing partnerships

Why are Kaiser Permanente staff considering a strike?

CDC's new outbreak response network to include Northeastern

explore

focus

entertainment

leisure time